Related content

Low molecular weight heparins: the optimal treatment for venous thromboembolism

By Daskalopoulos Marios E.   Daskalopoulou Stella S.   Liapis Christos D.  

Current Medical Research and Opinion, Vol. 20, Iss. 7, 2004-07 ,pp. : 1001-1005

Informa Healthcare

Access to resources Recommend Favorite

Does Low-Molecular-Weight Heparin Reduce the Costs of Venous Thromboembolism Treatment?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 136-140

Karger

Access to resources Recommend Favorite

Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 2, 2003-11 ,pp. : 64-67

Karger

Access to resources Recommend Favorite

Unfractionated Heparin and Low-Molecular-Weight Heparin for the Initial Treatment of Acute Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins: Are They Interchangeable?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 148-157

Karger

Access to resources Recommend Favorite